Held by the filer's joint per the disclosure. Disclosed 13 days after the transaction; reported as an official range, not an exact amount.
Traded Aug 6, 2026 · Filed Aug 7, 2026
A board member of Colgate-Palmolive sold $389K of Colgate-Palmolive shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$389,358
Shares × reported transaction price
6 days after results of Jul 31, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $93.00 on Aug 6, 2026, 24% above its 52-week low and 6% below its high, after a 1% rise over the previous 30 trading days
52-week range $74.98 (Nov 3, 2025) to $99.14 (Feb 27, 2026), 75% of the way up, from 251 adjusted closes. 30 trading days earlier: $91.88 on Jun 24, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -3.2% | -0.1% | -3.1% |
| 30 days | -5.5% | -1.4% | -4.1% |
Past results only. Not a forecast.
Held by the filer's joint per the disclosure. Disclosed 13 days after the transaction; reported as an official range, not an exact amount.
75K → 65K shares held−13% of their stake
Colgate-Palmolive's COO, CD, EMEA, APac, Skin sold $920K of Colgate-Palmolive shares. Nobody planned it ahead of time.
From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.